Loading provider…
Loading provider…
Clinical Neurophysiology Physician in Washington, DC
NPI: 1033209309Primary Practice Location
CHILDREN'S NATIONAL HOSPITAL
111 Michigan Ave Nw, Washington, DC
Primary Employer
Children's National Medical Associates
childrensnational.org
HQ Phone
Get MD Adelaide's Phone Numberphone_androidMobile
Get MD Adelaide's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
DC State Medical License
1990 - 2027
VA State Medical License
2000 - 2026
MD State Medical License
1988 - 2025

American Board of Psychiatry and Neurology
Psychiatry

American Board of Psychiatry and Neurology
Child & Adolescent Psychiatry
Children's National Hospital/George Washington University
Fellowship • Child and Adolescent Psychiatry
1994 - 1996
Johns Hopkins University
Residency • Psychiatry
1987 - 1990
The Johns Hopkins University School of Medicine
hopkinsmedicine.org
Medical School
Until 1987
Nocturnal nasogastric refeeding for hospitalized adolescent boys with anorexia nervosa.
Authors: Tomas Silber
Journal: J Dev Behav Pediatr
Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and Adolescents.
Authors: Robert Findling, Benedetto Vitiello, Daniel Connor, Jeffrey Newcorn, Birgit Amann
Journal: J Child Adolesc Psychopharmacol
Publication Date: 2019-08-27
Authors: Robb, Adelaide S, Silber, Tomas J, Orrell-Valente, Joan K, Valadez-Meltzer, Adela, Ellis, Nathan, Dadson, Michele J, Chatoor, Irene
Journal: Am J Psychiatry
Lead Sponsor: SyneuRx International (Taiwan) Corp
Intervention / Treatment: DRUG: Placebo, DRUG: NaBen®
Lead Sponsor: H. Lundbeck A/S
Collaborators: Takeda
Intervention / Treatment: OTHER: Placebo, DRUG: Fluoxetine 20mg/day, DRUG: Vortioxetine 10 mg/day, DRUG: Vortioxetine 20 mg/day
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin